Monday - Friday 8:00 - 16:30 Office Ferhadija 27, 71000 Sarajevo

Pancreatic cancer (PC) has a high mortality rate and is projected to become a massive public health problem in Europe. This Action will boost research on prevention of PC, particularly in the discovery of genetic risk factors, risk stratification, identification of biomarkers for early detection and patient monitoring, elucidation of biological mechanisms and functional pharmacogenomics for personalized medicine. These aims will be attained by expanding an existing interdisciplinary network.

Team member:

Lejla_Gurbeta_Pokvic.jpg

Merima Smajlhodžić Deljo, Senior Expert Associate

Learn more about the COST Action

ABOUT US RESEARCH PUBLICATION NEWS CONTACT

Verlab Research Institute for biomedical engineering, medical devices and artificial intelligence

Ferhadija 27, 71000 Sarajevo, Bosnia and Herzegovina +387 (33) 56 95 40 info@verlabinstitute.com

Verlab Institute is certified by ISO 21001

Quality Policy

Cookies

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it